Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.45 |
| ▸ | PPARG | P37231 | 5/20 | 0.43 |
| ▸ | PPARA | Q07869 | 5/20 | 0.42 |
| ▸ | PPARD | Q03181 | 3/20 | 0.42 |
| ▸ | PTGES | O14684 | 3/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.41 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7555489 | 0.82 | PPARG (0.43) | PPARGPPARAPTGESALOX5 | |
| SCHEMBL7069229 | 0.81 | PPARG (0.52) | MAOBPPARGPPARAPPARDALOX5 | |
| SCHEMBL7550529 | 0.80 | PTPN1 (0.50) | MAOBPPARGPTPN1 | |
| SCHEMBL7070132 | 0.75 | KMT2A (0.49) | MAOBPPARGPPARAALOX5MRGPRX4 | |
| SCHEMBL7066051 | 0.73 | PPARG (0.47) | MAOBPPARGPPARAPPARDPTGES | |
| SCHEMBL7556674 | 0.72 | MAOB (0.48) | MAOBPTPN1MAPT | |
| SCHEMBL7069231 | 0.70 | PPARG (0.39) | PPARGPPARAPTGESALOX5 | |
| SCHEMBL7069252 | 0.68 | MAOB (0.44) | MAOBPPARGPPARAPPARDALOX5 | |
| SCHEMBL20377544 | 0.68 | MAOB (0.75) | MAOBPPARAPPARDMRGPRX4 | |
| SCHEMBL7550100 | 0.67 | PPARA (0.60) | MAOBPPARGPPARAPPARDPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020032330-A1 | Propionic acid derivatives | NOMURA YUTAKA (JP) | 2002-03-14 | — | — | US | disclosed |
| EP-0994095-A1 | PROPIONIC ACID DERIVATIVES | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032330-A1 | Propionic acid derivatives | ABAT, ACAT1, PDXK | MAOB 1256/4885PPARG 123/4885PPARA 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.